CLINICAL_TRIALS
trial_result
· 2021-07-06
Clinical Trial Update: Prostvac in Patients With Biochemically Recurrent Prostate Cancer [Phase 2]
Summary
Phase 2 trial update for Prostvac in biochemically recurrent prostate cancer; results completed with posted results in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-07-06